Peer review reports
From: Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen
Original Submission | ||
---|---|---|
13 Feb 2024 | Submitted | Original manuscript |
2 Mar 2024 | Reviewed | Reviewer Report |
4 Mar 2024 | Reviewed | Reviewer Report - Nyasha Chin’Ombe |
8 Apr 2024 | Reviewed | Reviewer Report |
19 Apr 2024 | Author responded | Author comments - Falasca Katia |
Resubmission - Version 2 | ||
19 Apr 2024 | Submitted | Manuscript version 2 |
22 Apr 2024 | Author responded | Author comments - Falasca Katia |
Resubmission - Version 3 | ||
22 Apr 2024 | Submitted | Manuscript version 3 |
24 Apr 2024 | Author responded | Author comments - Falasca Katia |
Resubmission - Version 4 | ||
24 Apr 2024 | Submitted | Manuscript version 4 |
5 May 2024 | Reviewed | Reviewer Report |
22 May 2024 | Reviewed | Reviewer Report |
4 Jun 2024 | Author responded | Author comments - Falasca Katia |
Resubmission - Version 5 | ||
4 Jun 2024 | Submitted | Manuscript version 5 |
6 Jun 2024 | Author responded | Author comments - Falasca Katia |
Resubmission - Version 6 | ||
6 Jun 2024 | Submitted | Manuscript version 6 |
25 Jun 2024 | Reviewed | Reviewer Report |
Resubmission - Version 7 | ||
Submitted | Manuscript version 7 | |
Publishing | ||
25 Jun 2024 | Editorially accepted | |
3 Jul 2024 | Article published | 10.1186/s12879-024-09565-w |